Dorsey & Whitney Trust’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.75M | Buy |
5,923
+1,151
| +24% | +$342K | 0.1% | 189 |
|
|
2025
Q4 | $1.3M | Buy |
4,772
+256
| +6% | +$69.6K | 0.07% | 229 |
|
|
2025
Q3 | $1.22M | Buy |
4,516
+61
| +1% | +$16.6K | 0.06% | 243 |
|
|
2025
Q2 | $1.23M | Sell |
4,455
-311
| -7% | -$84.6K | 0.07% | 233 |
|
|
2025
Q1 | $1.26M | Buy |
4,766
+451
| +10% | +$111K | 0.07% | 230 |
|
|
2024
Q4 | $1M | Buy |
4,315
+91
| +2% | +$20.9K | 0.06% | 264 |
|
|
2024
Q3 | $932K | Sell |
4,224
-103
| -2% | -$21.3K | 0.05% | 274 |
|
|
2024
Q2 | $851K | Buy |
4,327
+237
| +6% | +$49K | 0.06% | 244 |
|
|
2024
Q1 | $881K | Sell |
4,090
-319
| -7% | -$67K | 0.06% | 238 |
|
|
2023
Q4 | $929K | Sell |
4,409
-80
| -2% | -$17.1K | 0.07% | 221 |
|
|
2023
Q3 | $899K | Buy |
4,489
+60
| +1% | +$11.9K | 0.08% | 212 |
|
|
2023
Q2 | $821K | Sell |
4,429
-31
| -0.7% | -$5.73K | 0.07% | 234 |
|
|
2023
Q1 | $854K | Sell |
4,460
-332
| -7% | -$60K | 0.08% | 221 |
|
|
2022
Q4 | $806K | Sell |
4,792
-486
| -9% | -$84.5K | 0.08% | 226 |
|
|
2022
Q3 | $935K | Buy |
5,278
+364
| +7% | +$71.9K | 0.1% | 187 |
|
|
2022
Q2 | $1M | Buy |
4,914
+113
| +2% | +$24K | 0.1% | 183 |
|
|
2022
Q1 | $1.14M | Buy |
4,801
+137
| +3% | +$32.2K | 0.1% | 177 |
|
|
2021
Q4 | $1.07M | Sell |
4,664
-438
| -9% | -$96.4K | 0.09% | 190 |
|
|
2021
Q3 | $986K | Buy |
5,102
+46
| +0.9% | +$9.32K | 0.09% | 187 |
|
|
2021
Q2 | $1.07M | Sell |
5,056
-344
| -6% | -$72.6K | 0.1% | 180 |
|
|
2021
Q1 | $1.1M | Sell |
5,400
-14
| -0.3% | -$2.76K | 0.11% | 181 |
|
|
2020
Q4 | $985K | Buy |
5,414
+141
| +3% | +$24K | 0.11% | 162 |
|
|
2020
Q3 | $882K | Buy |
5,273
+312
| +6% | +$52.6K | 0.12% | 162 |
|
|
2020
Q2 | $807K | Buy |
4,961
+258
| +5% | +$46.2K | 0.11% | 165 |
|
|
2020
Q1 | $813K | Sell |
4,703
-471
| -9% | -$93.7K | 0.14% | 147 |
|
|
2019
Q4 | $1.04M | Buy |
5,174
+240
| +5% | +$49.2K | 0.14% | 144 |
|
|
2019
Q3 | $1.04M | Buy |
4,934
+117
| +2% | +$24.4K | 0.15% | 135 |
|
|
2019
Q2 | $935K | Sell |
4,817
-28
| -0.6% | -$5.16K | 0.14% | 142 |
|
|
2019
Q1 | $797K | Buy |
4,845
+270
| +6% | +$47.7K | 0.12% | 150 |
|
|
2018
Q4 | $860K | Buy |
4,575
+65
| +1% | +$12K | 0.15% | 133 |
|
|
2018
Q3 | $768K | Buy |
4,510
+194
| +4% | +$32.7K | 0.12% | 143 |
|
|
2018
Q2 | $706K | Buy |
4,316
+236
| +6% | +$38.5K | 0.12% | 144 |
|
|
2018
Q1 | $660K | Buy |
4,080
+960
| +31% | +$153K | 0.12% | 139 |
|
|
2017
Q4 | $456K | Hold |
3,120
| – | – | 0.08% | 174 |
|
|
2017
Q3 | $424K | Buy |
3,120
+26
| +0.8% | +$3.29K | 0.08% | 175 |
|
|
2017
Q2 | $387K | Buy |
3,094
+95
| +3% | +$11.4K | 0.08% | 195 |
|
|
2017
Q1 | $357K | Buy |
2,999
+222
| +8% | +$26.7K | 0.07% | 196 |
|
|
2016
Q4 | $320K | Buy |
2,777
+382
| +16% | +$42.5K | 0.07% | 189 |
|
|
2016
Q3 | $251K | Sell |
2,395
-228
| -9% | -$23.8K | 0.06% | 219 |
|
|
2016
Q2 | $256K | Buy |
+2,623
| New | +$248K | 0.06% | 217 |
|
|
2013
Q3 | – | Sell |
-6,460
| Closed | -$491K | – | 264 |
|
|
2013
Q2 | $491K | Buy |
+6,460
| New | +$424K | 0.16% | 111 |
|
Other funds holding CME
VCM
VPM
Dorsey & Whitney Trust's CME Position: Q1 2026 in Review
Dorsey & Whitney Trust increased its CME Group (CME) stake by 24% in Q1 2026, buying an estimated $342K and bringing the position to 5,923 shares worth $1.75M. The position accounts for 0.1% of the portfolio, ranked #189.
Dorsey & Whitney Trust first reported a position in CME in Q2 2013 and has held it in 41 quarters since. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Dorsey & Whitney Trust held 5,923 shares of CME Group worth $1.75M as of Q1 2026.
- Dorsey & Whitney Trust bought 1,151 CME Group shares in Q1 2026, an estimated $342K.
- CME Group made up 0.1% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #189 holding.
- Dorsey & Whitney Trust first reported a position in CME Group in Q2 2013 and has held it in 41 quarters since.
- 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.